Stocks Up as Bullar...
Health Care: Drugs
Sanofi (SNY: NYSE)
$55.05 1.21 | 2.25%
05/21/13 - 04:02 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 6.57B | 7.38B | 7.33B | 7.55B |
| Operating Gains/Losses | -113.74M | -44.07M | 517.84M | 220.95M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 486.68M | -333.10M | -110.01M | -615.50M |
| (Increase) Decrease in Inventories | -588.52M | -300.69M | -507.10M | -701.59M |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 88.61M | -112.76M | 37.56M | -482.07M |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Working Capital | -425.85M | 79.06M | 207.94M | 583.94M |
| Other Non-Cash Items | -488.00M | 821.72M | 759.31M | 144.91M |
| Net Cash From Continuing Operations | 10.81B | 12.27B | 13.09B | 12.22B |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 10.81B | 12.27B | 13.09B | 12.22B |
| Sale of Property, Plant & Equipment | 473.46M | 0.00 | 175.74M | 121.95M |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -2.13B | -2.31B | -2.11B | -2.56B |
| Acquisitions | -372.95M | -17.61B | -2.23B | -7.98B |
| Purchases of Short-Term Investments | -60.84M | -33.70M | -99.27M | -7.17M |
| Other Cash from Investing Activities | -6.61M | 903.38M | -279.04M | -27.26M |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -2.10B | -19.05B | -4.54B | -10.45B |
| Issuance of Debt | 1.56B | 10.83B | 1.09B | 6.74B |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 854.34M | 94.61M | 100.62M | 241.04M |
| Repayment of Long-Term Debt | -1.78B | -3.80B | -2.66B | -3.98B |
| Repurchase of Capital Stock | -1.09B | -1.39B | -430.64M | 0.00 |
| Payment of Cash Dividends | -13.23M | -1.80B | -4.21B | -4.13B |
| Other Financing Charges, Net | -5.29B | -187.93M | -130.13M | 0.00 |
| Net Cash From Financing Activities | -5.75B | 3.75B | -6.23B | -1.13B |
| Effect of Exchange Rate Changes | 31.74M | 1.30M | 59.03M | 35.87M |
| Net Change in Cash & Cash Equivalents | 2.98B | -3.03B | 2.38B | 668.59M |
Portfolios with SNY
- Portfolio NameUser Type
- ProWarren Buffett
- ContributorTechnical Setups for the We...
- ContributorStocks Rising On Unusual Vo...
- ProKen Fisher - Fisher Investm...
- ContributorHigh Volume Technicals for ...
- ContributorRocket Stocks for the Week ...
- Contributor9 Stocks to Buy for a Europ...
- ContributorDrugs Facing FDA Approval i...
- Contributor7 Big-Pharma Stocks With Un...
- UserLong Term Stock Picks
Latest SNY Headlines from TheStreet
- Sanofi (SNY): Today's Featured Drugs Laggard 05.20.13 | 05:05 pm
- 5 Stocks Underperforming Today In The Drugs Industry 05.20.13 | 01:05 pm
- Sanofi Stock Buy Recommendation Reiterated (SNY) 05.13.13 | 10:05 am
- Sanofi (SNY): Today's Featured Drugs Winner 05.07.13 | 05:05 pm
- 5 Stocks Dragging In The Health Care Sector 05.06.13 | 01:05 pm
- Sanofi Stock Buy Recommendation Reiterated (SNY) 05.03.13 | 10:05 am
- Sanofi Stock Hits New 52-Week High (SNY) 05.02.13 | 04:05 pm
- 5 Drugs Stocks Nudging The Industry Higher 04.29.13 | 01:04 pm
- Sanofi (SNY): Today's Featured Health Care Laggard 04.25.13 | 05:04 pm
- Sanofi Reaches New 52-Week High (SNY) 04.24.13 | 09:04 am
Press Releases for SNY
- Football Legend Jerome Bettis & Sanofi US Tackle Anaphylaxis During National Asthma And Allergy Awareness Month - PR Newswire 05.16.13 | 08:05 am
- New Gold Bond® No Mess Powder Spray Introduced By Sanofi's Chattem - PR Newswire 05.06.13 | 03:05 pm
- Sanofi US And Actress Elizabeth Perkins Premiere Documentary -- Diabetes Co-Stars Presents "Strength In Numbers" - PR Newswire 05.06.13 | 08:05 am
- NextBio Announces Translational Medicine Partnership With Sanofi - PR Newswire 04.30.13 | 08:04 am
- U.S. FDA Grants Fast-Track Designation To Sanofi Pasteur And KaloBios' Novel Biologic Candidate For Pseudomonas Aeruginosa - PR Newswire 04.23.13 | 08:04 am
- New Allegra® Anti-Itch Cream Introduced By Sanofi's Chattem - PR Newswire 04.11.13 | 08:04 am
- Basketball Legend Lisa Leslie Teams Up With Allegra® To Help Families Enjoy Outdoor Workouts This Allergy Season - PR Newswire 03.28.13 | 10:03 am
- Sanofi And Transgene Announce Innovative Long-Term Collaboration For The Production Of Immunotherapy Treatments - Business Wire 03.25.13 | 02:03 am
- Genzyme Receives Positive CHMP Opinion In The European Union For Once-daily, Oral AUBAGIO® To Treat Relapsing-Remitting Multiple Sclerosis - Business Wire 03.22.13 | 08:03 am
- Effect Of Genzyme’s LEMTRADA™ Maintained In Patients Beyond Two-Year Pivotal MS Studies - Business Wire 03.21.13 | 03:03 pm
Partner Headlines for SNY
- Regeneron's Flagship Drug Treats Blindness In Seniors - Investor's Business Daily 04.11.13 | 05:04 pm
- 10 Sharp Healthcare Dogs Diagnose 7.4% To 62.1% Gains In March - Seeking Alpha 04.01.13 | 09:04 am
- 5 Dividends Stocks From Billionaire Ken Fisher - Seeking Alpha 03.28.13 | 09:03 am
- Biogen MS Drug Approved; No 'Black Box' Label - Investor's Business Daily 03.27.13 | 06:03 pm
- Moves in Smaller Health Care Stocks (ANAC, HALO, PBYI, QCOR) - Benzinga 03.23.13 | 11:03 am
- Top 9 March Healthcare Dogs Mark 3.4% To 28.7% Gains - Seeking Alpha 03.23.13 | 04:03 am
- Celgene, Regeneron Get Some Favorable News - Investor's Business Daily 02.13.13 | 06:02 pm
- Celgene, Regeneron Get Some Favorable News - Investor's Business Daily 02.11.13 | 06:02 pm
- Novo Nordisk Hit By Diabetes Drug Delay; Sanofi Rises - Investor's Business Daily 02.11.13 | 05:02 pm
- Stocks Narrow To Thin Red Line; Generac Backslides - Investor's Business Daily 02.11.13 | 12:02 pm
